中藥減毒藥方（淨冠方）用於新冠肺炎確診家族追蹤分析

The Using of Chinese Medicine Decoction, Jing-Guan-Fang, in Confirmed Cases and Their Exposed Family of COVID-19 Infection

10.7102/JTCIM.202112_19(2).0002

戴毓萱(Yu-Hsuan, Tai)；魏任宣(Renn-Shiuan, Wei)；陳建宏(Chien-Hung, Chen)；許中華(Chung-Hua, Hsu)

新冠肺炎 ； 衛氣營血證型 ； 淨冠方 ； 中藥 ； COVID-19 ； ＂defense, qi, nutrient and blood pattern＂ identification ； Jing-Guan-Fang(JFG) ； Chinese herbal medicine

中醫內科醫學雜誌

19卷2期（2021 / 12 / 01）

13 - 24

繁體中文

新型冠狀病毒，即吳又可《溫疫論．原序》提及：「夫瘟疫之為病，非風非寒非暑非濕，乃天地間別有一種異氣所感。」此疾病與古書記載之溫病相似，其症狀高熱、咳嗽、喘促、缺氧、腹瀉等，可對應「衛氣營血」病程傳變。據研究，不少案例為家戶群聚感染，故此文探討本院中藥減毒藥方－淨冠方，對於一個家族內確診者、隔離者、高危接觸者、一般接觸者之效果展現。除記錄該家族成員服藥狀況，亦深入討論其中一例併用瑞德西韋與淨冠方之確診者。治療成果顯示，該患者經合併治療後，症狀迅速減輕且比預期時間提早出院。本院院內製劑淨冠方，目的為清宣上焦與解肌之熱邪，達淨化與弱化癘氣之效，即時阻絕傳變，減緩病程發展。對於高危接觸者與隔離者，提供可能的預防效果。面臨家族成員感染時，無論確診、隔離、或（高危）接觸者，淨冠方的盡速使用是一個良好的選擇。

COVID-19, as one kind of pandemic diseases, conforms to the concept of plaque proposed by Wu's academic work ＂On Warm Epidemics＂ that patients were infected with a certain substance in air, neither extreme climate nor changes in nature. This disease also fit to the description of warm disease recorded in ancient books. Its symptoms, such as high fever, cough, dyspnea, hypoxia, diarrhea, and etc., also correspond to the transmission and transmutation of ＂ defense, qi, nutrient and blood pattern ＂. According to domestic and foreign studies, household contacts is an important route of transmission of COVID-19. In this article we present the effects of the Chinese medicine decoction, Jing-Guan-Fang (JGF), in the treatment of confirmed cases and associated household contacts: in one confirmed case who underwent combined treatment with Remdesivir and JGF, the symptoms improved quickly and the patient was discharged earlier than expected; and in high risk contacts none developed COVID-19 infection. The results indicated that JFG can drain the heat of upper fire, release the flesh, and make pathogen declined. JFG instantly stop transmission and transmutation, reduce the progress of the disease. For high-risk contacts and quarantined people, it can also provide possible preventive effects. The JKF can provide a good treatment choice for many clinical situations.

1. 許詠棠、蔡金川, Chin-Chuan,洪裕強, Yu-Chiang(2020)。新型冠狀病毒肺炎中醫瘟疫試治。中醫內科醫學雜誌，18(2)，12-34。
   連結：
2. Our World in Data. Coronavirus (COVID-19) Vaccinations. Cited Sep 27, 2021. Available at: https://ourworldindata.org/covid-vaccinations
3. (2003)。專題座談：中西結合防治 SARS。中國中西結合雜誌，23(7)，484-485。
4. Beigel, J.H.(2020).Remdesivir for the Treatment of Covid-19 -Final Report.N Engl J Med,383(19)
5. Beigel, J.H.(2020).Remdesivir for the Treatment of Covid-19 - Final Report.N Engl J Med,383(19),1813-1826.
6. Calina, Daniela,Docea, Anca Oana,Petrakis, Demetrios(2020).Towards effective COVID-19 vaccines: Updates, perspectives and challenges (Review).Int J Mol Med.,46(1),3-16.
7. Hsu, C,Hwang, K,Chao, C(2008).An Evaluation of the Additive Effect of Natural Herbal Medicine on SARS or SARS-like Infectious Diseases in 2003: a Randomized, Double-blind, and Controlled Pilot Study.Evid Based Complement Alternat Med,5(3),355-362.
8. Hsu, C,Hwang, KC,Chao, CL,Chang, SGN,Ker, CC,Chien, LC,Ho, MS,Lin, JG,Chen, YM,Chou, P(2006).The lesson of supplementary treatment with Chinese medicine on severe laboratory-confirmed SARS patients.The American Journal of Chinese Medicine,34,927-935.
9. Hsu, C,Hwang,KC,Chao, CL,Chang, SGN,Lin, JG,Ho, MS,Chou, P(2006).Can herbal medicine assist against avian flu? Learning the experience of using supplementary treatment with Chinese herbal medicine on SARS or SARS-like infectious disease in 2003.Journal of Alternative and Complementary Medicine,12,505-509.
10. Hsu, Chen-Yang,Wang, Jann-Tay,Huang, Kuo-Chin,Fan, Antoria Chiao-Hsin,Yeh, Yen-Po,Chen, Sam Li-Sheng(2021).Household transmission but without the community-acquired outbreak of COVID-19 in Taiwan.J Formos Med Assoc,120(Suppl 1),S38-S45.
11. Li, Fang,Li, Yuan-Yuan,Liu, Ming-Jin(2021).Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study.The Lancet Infectious Diseases,21(5),617-628.
12. Lin, W(2020).War and balance: Following shi and rebalancing militant English-language knowing apparatuses.The Sociological Review Monographa,68(2),341-355.
13. Metlay, Joshua P.,Haas, Jennifer S.,Soltoff, Alexander E.(2021).Household Transmission of SARS-CoV-2.JAMA Netw Open,4(2),e210304.
14. Organization WH. Clinical management of severe acute respiratory infection when novel coronavirus. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: Interim guidance 2020;21-2. Available at: https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected
15. Whitworth, J(2020).COVID-19: a fast evolving pandemic.Trans R Soc Trop Med Hyg,114(4),241-248.
16. Wu, Zunyou,McGoogan, Jennifer M.(2020).Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China.JAMA,323(13),1239-1242.
17. 何彥頤,陳建中,謝抒玲,許中華(2003)。嚴重急性呼吸道症候（SARS）之中醫診治與臨床實例。中國中醫臨床醫學雜誌，9(3)，22-24。
18. 何彥頤,陳建中,謝抒玲,許中華(2003)。從 SARS來襲談時疫防治之道。中國中醫臨床醫學雜誌，9(3)，25-27。
19. 許中華,黃焜璋,趙崇良(2004)。從衛氣營血辨症分析 SARS 疾病傳變。臺灣中醫醫學雜誌，3(1)，68-80。
20. 衛生福利部疾病管制署，COVID-19 專區。Cited July 25, 2021. Available at: https://sites.google.com/cdc.gov.tw/2019ncov/taiwan
21. 衛生福利部疾病管制署，新型冠狀病毒（SARS-CoV-2）感染臨床處置暫行指引第十三版。Cited July 13, 2021. Available at: https://www.cdc.gov.tw/Category/Page/xCSwc5oznwcqunujPc-qmQ
22. 衛生福利部疾病管制署，COVID-19 專區。Cited July 10, 2021. Available at: https://www.cdc.gov.tw/Bulletin/Detail/ftv6FPFis84j5uHWTq4lNA?typeid=8772
23. 衛生福利部疾病管制署，COVID-19 專區。嚴重特殊傳染性肺炎確診個案處置及解除隔離治療條。Cited Sep 3, 2021. Available at: https://www.cdc.gov.tw/File/Get/vPb7wlEHRYgiClByyrf7Ww

1. 謝明憲,雷才萱,黃建榮,許中華,邱榮鵬(2022)。新冠肺炎及類新冠肺炎者之證型分布及使用淨冠方之滿意。中醫內科醫學雜誌，20(2)，1-11。